- Trials with a EudraCT protocol (20)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
20 result(s) found for: Dent disease.
Displaying page 1 of 1.
EudraCT Number: 2006-005742-37 | Sponsor Protocol Number: 06/AN/02 | Start Date*: 2007-01-26 | |||||||||||
Sponsor Name:NHS Glasgow and Clyde / University of Glasgow | |||||||||||||
Full Title: Randomised clinical trial of the effects of total intravenous anaesthesia (TIVA: propofol) versus volatile anaesthesia (sevoflurane-N20 induction and isoflurane-N20 maintenance) on children’s post... | |||||||||||||
Medical condition: Dental caries | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-010725-39 | Sponsor Protocol Number: 56493 | Start Date*: 2009-07-23 | |||||||||||
Sponsor Name:The University of Manchester [...] | |||||||||||||
Full Title: A randomised controlled trial to measure the effects and costs of a dental caries prevention regime for young children attending primary care dental services | |||||||||||||
Medical condition: Dental Caries | |||||||||||||
|
|||||||||||||
Population Age: Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-023476-23 | Sponsor Protocol Number: SPON766-09 | Start Date*: 2011-03-17 | |||||||||||
Sponsor Name:Cardiff University | |||||||||||||
Full Title: Seal or Varnish? A Randomised Trial To Determine The Relative Cost And Effectiveness Of Pit And Fissure Sealants And Fluoride Varnish In Preventing Dental Decay | |||||||||||||
Medical condition: Dental Caries | |||||||||||||
|
|||||||||||||
Population Age: Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-002287-26 | Sponsor Protocol Number: GN12CO201 | Start Date*: 2012-10-24 | |||||||||||
Sponsor Name:Greater Glasgow and Clyde NHS Board [...] | |||||||||||||
Full Title: Comparison of the caries-protective effect of fluoride varnish (Duraphat®) with treatment as usual in nursery school attenders receiving preventive oral health support through the Childsmile Progra... | |||||||||||||
Medical condition: Childhood dental caries | |||||||||||||
|
|||||||||||||
Population Age: Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-000869-20 | Sponsor Protocol Number: DC0071-BB-404-8B | Start Date*: 2005-08-08 |
Sponsor Name:Pierre Fabre Médicament | ||
Full Title: Post-operative care by chlorhexidine mouthwash after periodontal surgery. Randomised, parallel groups; blind study, DC071BB versus placebo, in patients presenting with periodontal surgery with sutu... | ||
Medical condition: Post-operative care for patients having periodontal surgery with gingival suture. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Completed) EE (Completed) LV (Completed) | ||
Trial results: View results |
EudraCT Number: 2012-000260-17 | Sponsor Protocol Number: Intermed_Chlorhexidine_sol_0.2%_ | Start Date*: 2012-09-07 | |||||||||||||||||||||
Sponsor Name:IOULIA & IRENE TSETI PHARMACEUTICAL LABORATORIES S.A.-INTERMED S.A. | |||||||||||||||||||||||
Full Title: A therapeutic equivalence study, comparing two chlorhexidine digluconate formulations, the test formulation Chlorel® Or. T. Sol. 0,2% w / v and the reference formulation Corsodyl® 0.2% w / v Mint M... | |||||||||||||||||||||||
Medical condition: Therapeutic equivalence study, comparing two chlorhexidine digluconate formulations indicated for inhibition of the formation of dental plaque, as an aid in the treatment and prevention of gingivi... | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: GR (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2017-002402-13 | Sponsor Protocol Number: R04684 | Start Date*: 2018-02-02 | |||||||||||
Sponsor Name:Manchester University NHS Foundation Trust | |||||||||||||
Full Title: A Randomised controlled trial to Evaluate the effectiveness and cost benefit of prescribing high dose FLuoride toothpaste in preventing and treating dEntal Caries in high-risk older adulTs (REFLECT... | |||||||||||||
Medical condition: Dental caries in high-risk older adults | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-001697-42 | Sponsor Protocol Number: OML-III-A | Start Date*: 2017-08-30 | |||||||||||
Sponsor Name:Schülke & Mayr GmbH | |||||||||||||
Full Title: Randomized, placebo-controlled, parallel group, double-blind, multi-center Phase III study to assess the inhibition of plaque formation of 0.1% octenidine mouthwash vs placebo in subjects with a gi... | |||||||||||||
Medical condition: inhibition of plaque formation | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-001698-18 | Sponsor Protocol Number: OML-III-B | Start Date*: 2017-11-06 | |||||||||||
Sponsor Name:Schülke & Mayr GmbH | |||||||||||||
Full Title: Randomized, placebo-controlled, parallel group, double-blind, multi-center Phase III study to assess the inhibition of plaque formation of 0.1% octenidine mouthwash vs placebo in subjects with a gi... | |||||||||||||
Medical condition: inhibition of plaque formation | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) AT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-004837-54 | Sponsor Protocol Number: RABGRD3003 | Start Date*: 2009-03-05 | |||||||||||
Sponsor Name:Janssen-Cilag International NV | |||||||||||||
Full Title: A Multicenter, Double-Blind, Parallel-Group Study to Evaluate Short-Term Safety and Efficacy and Long-Term Maintenance of Two Dose Levels of Rabeprazole Sodium Delayed-Release Pediatric Bead Formul... | |||||||||||||
Medical condition: Endoscopically proven gastroesophageal reflux disease (GERD) in a paediatric population of 1 to 11 year old subjects. | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) BE (Completed) FR (Completed) NL (Ongoing) IT (Completed) BG (Not Authorised) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-001916-39 | Sponsor Protocol Number: AB0001 | Start Date*: 2016-09-09 | ||||||||||||||||
Sponsor Name:AZIENDA OSPEDALIERO-UNIVERSITARIA PISANA | ||||||||||||||||||
Full Title: A phase IV, single-blind, randomized, controlled, single-center study evaluating the efficacy of amoxicillin+clavulanic acid Vs no treatment in preventing complications after tooth extraction and t... | ||||||||||||||||||
Medical condition: teeth needing extraction due to infections | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: IT (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-005478-66 | Sponsor Protocol Number: PDY5808 | Start Date*: 2006-02-09 | |||||||||||
Sponsor Name:Sanofi-Synthelabo Recherche | |||||||||||||
Full Title: Effect of a single oral 120 µg dose of SSR150106XB compared to placebo on the assessment of post dental surgical pain after extraction of an impacted or partially impacted third molar in 90 male an... | |||||||||||||
Medical condition: Men and women who are to undergo elective surgery for extraction of at least one lower impacted or partially impacted third molar | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-004481-16 | Sponsor Protocol Number: VRA105345 | Start Date*: 2005-12-19 |
Sponsor Name:GlaxoSmithKline Research and Development | ||
Full Title: A multi-centre, randomised, single blind, placebo controlled, parallel group study to examine the effect of single doses of SB-705498, a TRPV1 receptor antagonist, on pain following third molar too... | ||
Medical condition: Dental pain | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) IT (Completed) | ||
Trial results: View results |
EudraCT Number: 2004-003657-99 | Sponsor Protocol Number: CP 204 | Start Date*: 2005-02-01 | |||||||||||
Sponsor Name:Arrow Therapeutics Ltd | |||||||||||||
Full Title: A double-blind, randomised, placebo controlled study to evaluate the safety and efficacy of A-60444 in adults with RSV infection following stem cell transplantation | |||||||||||||
Medical condition: Upper respiratory tract infection (as identified by regular surveillance of stem cell transplant patients) or stem cell transplant patients diagnosed as positive for respiratory syncytial virus (RSV). | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) ES (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-001849-41 | Sponsor Protocol Number: DOX-101 | Start Date*: 2012-06-18 | |||||||||||
Sponsor Name:Leids Universitair Medisch Centrum (LUMC) | |||||||||||||
Full Title: Two-part, Randomized, Placebo-controlled, Repeated Stepped Infusion Dose Study of the Pharmacodynamics of Doxapram when Co-administered with Opioids (Protocol – doxapram-101). | |||||||||||||
Medical condition: acute respiratory insufficiency, including such conditions as opioid and anesthetic-induced respiratory depression, post-anesthetic atelectasis, and central apneas (e.g., apnea of prematurity). | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-004506-15 | Sponsor Protocol Number: TAK-390MR_204 | Start Date*: 2015-12-10 | |||||||||||
Sponsor Name:Takeda Development Centre Europe Ltd. | |||||||||||||
Full Title: A Phase 2, Double-Blind, 12 Week, Multicenter Study to Assess the Safety and Effectiveness of Daily Oral Administration of Dexlansoprazole Delayed-Release Capsules in Pediatric Subjects Aged 1 to ... | |||||||||||||
Medical condition: Symptomatic nonerosive GERD in paediatric subjects aged 1 to 11 years | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) IT (Prematurely Ended) PT (Completed) PL (Trial now transitioned) LT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-000328-42 | Sponsor Protocol Number: CP-104 | Start Date*: 2007-08-03 | |||||||||||
Sponsor Name:Arrow Therapeutics Ltd | |||||||||||||
Full Title: A clinical pharmacology study to determine the pharmacokinetic , safety and tolerability profile and antiviral activity of multiple oral doses of A-831 in otherwise healthy male Hepatitis C carrie... | |||||||||||||
Medical condition: Male Hepatitis C carriers with compensated liver disease | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2022-003274-22 | Sponsor Protocol Number: 22093 | Start Date*: 2022-10-25 | ||||||||||||||||
Sponsor Name:Bayer HealthCare LLC | ||||||||||||||||||
Full Title: A Randomized, Double-Blind, Single-Dose, Parallel, Placebo-Controlled Pivotal Trial to Confirm the Efficacy of a Fixed Dose Combination Tablet of Naproxen Sodium and Caffeine to Effectively Allevia... | ||||||||||||||||||
Medical condition: Postoperative dental pain | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: Outside EU/EEA | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2020-002220-37 | Sponsor Protocol Number: UP-CLI-2020-001 | Start Date*: 2021-02-24 |
Sponsor Name:UNITHER Pharmaceuticals | ||
Full Title: Comparison of the analgesic effect of a new paracetamol formulation (paracetamol UNIFLASH) for buccal use and two different doses of an oral paracetamol form controlled versus placebo in patients s... | ||
Medical condition: Symptomatic short-term treatment of moderate pain | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Completed) IT (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2010-022798-32 | Sponsor Protocol Number: DEX-TRA 02 | Start Date*: 2010-12-14 | |||||||||||
Sponsor Name:Menarini Ricerche S.p.A. | |||||||||||||
Full Title: DOUBLE-BLIND, RANDOMISED, PLACEBO AND ACTIVE CONTROLLED, PARALLEL GROUP STUDY TO EVALUATE THE ANALGESIC EFFECT OF A SINGLE ORAL ADMINISTRATION OF FOUR DIFFERENT COMBINATION DOSES OF DKP.TRIS WITH T... | |||||||||||||
Medical condition: Severe pain following impacted third mandibular molar tooth extraction | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) DE (Completed) ES (Completed) HU (Completed) IT (Completed) PL (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
